{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:54:02Z","timestamp":1760853242828},"reference-count":11,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1507\/endocrj.k05-173","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T05:47:25Z","timestamp":1162273645000},"page":"687-691","source":"Crossref","is-referenced-by-count":6,"title":["Acromegaly Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS)"],"prefix":"10.1507","volume":"53","author":[{"given":"Ippei","family":"KANAZAWA","sequence":"first","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"YAMAGUCHI","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"YAMANE","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"MURAKAMI","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"SUGIMOTO","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\/Metabolism and Hematology\/Oncology, Shimane University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. QJ Med 39: 1-16."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00237-Z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Georgii-Hemming P, Wiklund HJ, Ljunggren O, Nilsson K (1996) Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 88: 2250-2258.","DOI":"10.1182\/blood.V88.6.2250.bloodjournal8862250"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hagg E, Asplund K, Holm J (1988) Acromegaly and multiple myeloma. Ann Intern Med 8: 437-438.","DOI":"10.7326\/0003-4819-109-5-437_2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tucci A, Bonadonna S, Cattaneo C, Ungari M, Giustina A, Guiseppe R (2003) Transformation of a MGUS to Overt Multiple Myeloma: The possible role of a pituitary macroadenoma secreting high levels of insulin-like growth factor 1. Leukemia Lymphoma 44: 543-545.","DOI":"10.1080\/1042819021000037895"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kyle RA (1982) Monoclonal gammopathy of undetermined significance (MGUS): a review. Clin Haematol 11: 123-150.","DOI":"10.1016\/S0308-2261(21)00325-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Klein I, Parveen G, Gavaler JS, Vanthiel DH (1982) Colonic polyps in patients with acromegaly. Ann Intern Med 97: 27-30.","DOI":"10.7326\/0003-4819-97-1-27"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Melmed S (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86: 2929-2934.","DOI":"10.1210\/jc.86.7.2929"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202"},{"key":"10","unstructured":"10. Ge NL, Rudikoff S (2000) Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood 15: 2856-2861."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mitsiades CS, Mitsuades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA, Garcia-Echeverria C, Pearson MA, Hofmann F, Anderson KC, Kung AL (2004) Inhibition of insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5: 221-230.","DOI":"10.1016\/S1535-6108(04)00050-9"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/5\/53_5_687\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:11:46Z","timestamp":1628046706000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/5\/53_5_687\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k05-173","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}